Treatment for Fertility Preservation

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Olive Fertility Centre, Vancouver, Canada
Fertility Preservation
Eligibility
18 - 65
Female
What conditions do you have?
Select

Study Summary

Whether it is for oncology or personal reasons, fertility preservation allows participants to preserve their oocytes (eggs) at their current age and condition for a better chance of having a baby in the future. In order to proceed with fertility preservation, participants will need to undergo in vitro fertilization (IVF), which is standard practice, and take stimulation medication to stimulate production of more follicles. The combination of both Rekovelle and Menopur for fertility preservation may increase ovarian response to stimulation and increase the number of oocytes retrieved to give better chances of embryos once the oocytes will be fertilized. The goal in this study is to understand the effect of oxydative stress on the quality of oocytes. For the purpose of the study and to evaluate this connection, serum levels of oxidative stress and cf-DNA in your blood will be measured. Oocyte quality will also be assessed with Magenta, a prediction tool utilizing artificial intelligence (AI). This method is non-invasive and has no risks on the oocytes.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Fertility Preservation

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: IVF stimulation cycle

At the end of IVF stimulation
Evaluation of oocyte quality by visualization
Change from baseline oxidative stress at the end of IVF controlled ovarian stimulaition
Evaluate the correlation between the oxidative stress and the quality of oocytes
IVF stimulation cycle
Assessment of good quality oocytes
Number of mature oocytes retrieved

Trial Safety

Safety Progress

1 of 3

Other trials for Fertility Preservation

Trial Design

0 Treatment Group

180 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: ivf stimulation cycle
Closest Location: Olive Fertility Centre · Vancouver, Canada
Photo of Vancouver 1Photo of Vancouver 2Photo of Vancouver 3
2017First Recorded Clinical Trial
1 TrialsResearching Fertility Preservation
6 CompletedClinical Trials

Who is running the clinical trial?

Clinique OvoLead Sponsor
20 Previous Clinical Trials
3,195 Total Patients Enrolled
Ferring PharmaceuticalsIndustry Sponsor
300 Previous Clinical Trials
439,459 Total Patients Enrolled

Eligibility Criteria

Age 18 - 65 · Female Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.